Position in JNJ
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$22,705,679
+$860,810 QoQ
Shares Held
89,403
+0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#694
of 4,676 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Caprock Group, LLC holds $186,163,406 across 16 Drug Manufacturers - General names. JNJ ranks #2 (12.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
68,190 | $81,789,138 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
89,403 | $22,705,679 | |
| 3 | AMGN |
Amgen Inc
|
51,552 | $18,668,010 | |
| 4 | ABBV |
AbbVie Inc.
|
62,909 | $15,830,420 | |
| 5 | MRK |
Merck & Co., Inc.
|
79,617 | $10,230,784 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
66,482 | $8,399,335 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
115,747 | $6,669,342 | |
| 8 | NVS |
Novartis AG
|
39,351 | $6,167,088 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,705,679 | 89,403 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $21,844,869 | 89,367 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $17,789,008 | 85,958 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $14,906,470 | 80,393 | Shares | Sole | 2025-11-06 | |
| 2025-03-31 | $12,441,150 | 75,019 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $10,739,625 | 74,261 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $12,142,831 | 74,928 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $10,229,299 | 69,987 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $7,355,044 | 46,495 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $7,510,824 | 47,919 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $7,484,099 | 48,052 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $8,001,236 | 48,340 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $7,317,240 | 47,208 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $6,454,967 | 36,541 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $6,290,503 | 38,507 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $6,848,335 | 38,580 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $6,614,400 | 37,321 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $7,028,924 | 41,088 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $6,864,073 | 42,502 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $7,178,051 | 43,572 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $6,325,174 | 38,486 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $6,219,342 | 39,518 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $6,190,579 | 41,581 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $4,848,078 | 34,474 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $4,171,638 | 31,813 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||